Related Experiment Videos
Suppression of experimental allergic encephalomyelitis by interferon
Immunological Communications
|January 1, 1982
Summary
Rat interferon (IFN) treatment significantly reduced the severity of experimental allergic encephalomyelitis (EAE), an autoimmune disease model. Low doses of IFN delayed EAE onset and suppressed paralysis in Lewis rats.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Immunology
Background:
- Experimental allergic encephalomyelitis (EAE) is a T-cell dependent autoimmune disease model of the central nervous system.
- EAE is induced by injecting myelinated neural tissue in complete Freund's adjuvant.
Purpose of the Study:
- To investigate the therapeutic potential of rat interferon (IFN) in ameliorating EAE.
- To determine the effect of specific doses of IFN on EAE onset and symptom severity.
Main Methods:
- Induction of EAE in Lewis rats.
- Administration of rat interferon (IFN) at doses of 10(4.6) Units/kg and 10(5.6) U/Kg.
- Observation and assessment of EAE onset and clinical symptoms, including hind limb paralysis.
Main Results:
- Low doses of rat interferon (IFN) (10(4.6) Units/kg) delayed EAE onset and reduced symptom severity.
- Higher doses of IFN (10(5.6) U/Kg) suppressed hind limb paralysis in 70-80% of EAE-induced rats.
Conclusions:
- Rat interferon (IFN) demonstrates therapeutic efficacy in the EAE model.
- IFN treatment can effectively suppress key clinical manifestations of EAE, including paralysis.